Alector (ALEC) Treasury Shares (2018 - 2025)
Alector (ALEC) posted quarterly Treasury Shares of $3.9 million for Q4 2025, down 53.65% year-over-year from $8.4 million in Q4 2024, and down 53.65% quarter-over-quarter from $8.4 million in Q4 2024.
Alector (ALEC) Treasury Shares (2018 - 2025) Analysis & Trends
Alector (ALEC) has reported Treasury Shares for 8 consecutive years, with $3.9 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Treasury Shares fell 53.65% year-over-year to $3.9 million; the TTM figure through Dec 2025 stood at $3.9 million (down 53.65% YoY), while the FY2025 annual figure was $3.9 million, down 53.65% from the prior year.
- Treasury Shares eased to $3.9 million in Q4 2025 per ALEC's latest filing, from $8.4 million in the prior quarter.
- Across five years, Treasury Shares topped out at $8.4 million in Q4 2024 and bottomed at $100881.0 in Q1 2021.
- Historically, Treasury Shares has averaged $2.7 million across 5 years, with a median of $1.4 million in 2022.
- Annual changes were most pronounced in 2021 — Treasury Shares sank 87.39% — and 2022, when it soared 1223.71%.
- Alector's Treasury Shares stood at $1.4 million in 2021, then jumped by 121.61% to $3.0 million in 2022, then jumped by 100.09% to $6.1 million in 2023, then surged by 37.31% to $8.4 million in 2024, then plunged by 53.65% to $3.9 million in 2025.
- Business Quant data shows ALEC's Treasury Shares at $3.9 million in Q4 2025, $8.4 million in Q4 2024, and $6.1 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.88 Mn |
| Dec 31, 2025 | 3.88 Mn |
| Dec 31, 2024 | 8.37 Mn |
| Dec 31, 2024 | 8.37 Mn |
| Dec 31, 2023 | 6.09 Mn |
| Dec 31, 2023 | 6.09 Mn |
| Jun 30, 2023 | 3.04 Mn |
| Jun 30, 2023 | 3.04 Mn |
| Mar 31, 2023 | 3.12 Mn |
| Mar 31, 2023 | 3.12 Mn |
| Dec 31, 2022 | 3.04 Mn |
| Dec 31, 2022 | 3.04 Mn |
| Sep 30, 2022 | 1.40 Mn |
| Sep 30, 2022 | 1.40 Mn |
| Jun 30, 2022 | 1.36 Mn |
| Jun 30, 2022 | 1.36 Mn |
| Mar 31, 2022 | 1.34 Mn |
| Mar 31, 2022 | 1.34 Mn |
| Dec 31, 2021 | 1.37 Mn |
| Dec 31, 2021 | 1.37 Mn |